These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803 [TBL] [Abstract][Full Text] [Related]
6. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874 [TBL] [Abstract][Full Text] [Related]
8. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407 [TBL] [Abstract][Full Text] [Related]
9. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM; Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340 [TBL] [Abstract][Full Text] [Related]
10. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control]. Widimský J Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236 [TBL] [Abstract][Full Text] [Related]
11. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial. Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480 [TBL] [Abstract][Full Text] [Related]
12. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. ; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW; Oparil S; Rahman M; Reboussin DM; Rocco MV; Sink KM; Snyder JK; Whelton PK; Williamson JD; Wright JT; Ambrosius WT N Engl J Med; 2021 May; 384(20):1921-1930. PubMed ID: 34010531 [TBL] [Abstract][Full Text] [Related]
13. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial. Sink KM; Evans GW; Shorr RI; Bates JT; Berlowitz D; Conroy MB; Felton DM; Gure T; Johnson KC; Kitzman D; Lyles MF; Servilla K; Supiano MA; Whittle J; Wiggers A; Fine LJ J Am Geriatr Soc; 2018 Apr; 66(4):679-686. PubMed ID: 29601076 [TBL] [Abstract][Full Text] [Related]
14. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT). Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807 [TBL] [Abstract][Full Text] [Related]
15. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. ; Wright JT; Williamson JD; Whelton PK; Snyder JK; Sink KM; Rocco MV; Reboussin DM; Rahman M; Oparil S; Lewis CE; Kimmel PL; Johnson KC; Goff DC; Fine LJ; Cutler JA; Cushman WC; Cheung AK; Ambrosius WT N Engl J Med; 2015 Nov; 373(22):2103-16. PubMed ID: 26551272 [TBL] [Abstract][Full Text] [Related]
16. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial. Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Musini VM; Nazer M; Bassett K; Wright JM Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750 [TBL] [Abstract][Full Text] [Related]
18. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial). Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214 [TBL] [Abstract][Full Text] [Related]
19. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR; Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312 [TBL] [Abstract][Full Text] [Related]